Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

1.4K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

177
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
177
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

149
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

194
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

816
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
816

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Quality Improvement Project to Increase Breastfeeding Rates in the NICU.

Neonatal network : NN·2026
Same author

Examining Risk Factors and Characteristics of Trafficked Youth: Insights From a Therapeutic Housing Program.

Journal of forensic nursing·2025
Same author

Protocol for a pilot study assessing a virtual mindfulness intervention for postpartum African American women.

Brain behavior and immunity integrative·2024
Same author

Changes in postpartum contraception utilization rates during the early stage of the COVID-19 pandemic.

Women's health (London, England)·2023
Same author

Does regular walking improve lipid levels in adults?

The Journal of family practice·2023
Same author

Reducing Disparities in Postpartum Care Utilization: Development of a Clinical Risk Assessment Tool.

Journal of midwifery & women's health·2022

Related Experiment Video

Updated: Dec 23, 2025

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
07:56

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Published on: January 26, 2018

17.1K

Pharmacology for Preterm Labor.

Lindsey Garfield1, Emily Chin

  • 1Marcella Niehoff School of Nursing, Loyola University Chicago, Chicago, Illinois.

The Journal of Perinatal & Neonatal Nursing
|April 26, 2020
PubMed
Summary
This summary is machine-generated.

Preterm birth management involves medications to prolong pregnancy, mature fetal lungs, and reduce contractions. This review compares guidelines for pharmacologic treatment of preterm labor.

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.3K
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
04:18

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

232

Related Experiment Videos

Last Updated: Dec 23, 2025

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
07:56

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Published on: January 26, 2018

17.1K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.3K
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
04:18

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

232

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Pharmacology

Background:

  • Preterm birth complicates 10% of deliveries, causing over 85% of perinatal morbidity and mortality.
  • Current management strategies for preterm labor involve a pharmacologic approach to prolong gestation.
  • Key goals include promoting fetal lung maturity and inhibiting uterine contractions (tocolysis).

Purpose of the Study:

  • To review and compare current guidelines on the pharmacologic management of preterm labor.
  • To provide a comprehensive overview of drug classes used in preterm labor management.
  • To compare recommendations from the American College of Obstetricians and Gynecologists (ACOG) and the European Association of Perinatal Medicine (EAPM).

Main Methods:

  • Comparative review of ACOG and EAPM guidelines for preterm labor pharmacotherapy.
  • Classification and discussion of drug categories: progesterone, corticosteroids, and various tocolytics.
  • Detailed examination of each drug class, including mechanism of action, side effects, and nursing implications.

Main Results:

  • Guidelines offer varied recommendations on the use of progesterone, corticosteroids, and tocolytics.
  • Tocolytic agents discussed include beta-adrenergic agonists, magnesium sulfate, calcium channel blockers, prostaglandin inhibitors, nitrates, and oxytocin receptor blockers.
  • Comparative analysis highlights similarities and differences in drug selection and application between ACOG and EAPM.

Conclusions:

  • Pharmacologic management of preterm labor requires a multifaceted approach guided by established protocols.
  • Understanding the mechanism of action, side effects, and nursing implications is crucial for effective treatment.
  • Adherence to guideline recommendations can optimize outcomes for mother and neonate in cases of preterm labor.